- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
E2F transcription factor 4 (E2F4) is a member of the E2F family of transcription factors that play central roles in regulating cell cycle progression, DNA synthesis, and cellular proliferation. E2F4 functions predominantly as a transcriptional repressor and is a key component of the retinoblastoma (RB) pathway, where it contributes to the control of genes required for entry into the S phase of the cell cycle. E2F4 Antibody, clone E2F4/4224, is a mouse monoclonal antibody developed to detect this important nuclear regulator of cell cycle-dependent transcription.
E2F4 forms complexes with pocket proteins such as p107 and p130, which facilitate its localization to the nucleus and its ability to repress transcription of target genes involved in cell cycle progression. In quiescent and differentiated cells, E2F4 is typically found in the nucleus bound to these regulatory proteins, where it suppresses genes required for proliferation. Upon cell cycle activation, changes in pocket protein interactions alter E2F activity, enabling transcriptional programs that drive DNA replication and cell division.
Unlike activating E2F family members such as E2F1, E2F4 lacks a strong transactivation domain and instead primarily functions to maintain cells in a non-proliferative or differentiated state. It is widely expressed across tissues and is particularly important in controlling the balance between proliferation and differentiation. This role makes E2F4 a valuable marker for studying cell cycle control, tissue homeostasis, and developmental processes.
E2F4 localization can vary between nuclear and cytoplasmic compartments depending on cell type and cell cycle status, reflecting its dynamic regulation. Its association with the DREAM complex further integrates E2F4 into broader transcriptional repression networks that coordinate cell cycle exit and maintenance of quiescence. These features support the use of an E2F4 Antibody for investigating transcriptional control mechanisms and cell cycle regulation across diverse biological systems.
Altered regulation of E2F4 and associated pathways has been implicated in cancer and other proliferative disorders. Disruption of RB pathway components can lead to deregulated E2F activity, contributing to uncontrolled cell division. The ability to detect E2F4 expression and localization provides insight into these regulatory networks, supporting studies of tumor biology, differentiation, and cell cycle-dependent gene expression.
This antibody is part of a broader antibody panel offered by NSJ Bioreagents.
Optimal dilution of the E2F4 Antibody / Cell Cycle Regulation and Transcriptional Repressor Marker should be determined by the researcher.
A recombinant partial protein sequence (within amino acids 1-100) from the human protein was used as the immunogen for the E2F4 antibody.
Aliquot the E2F4 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
E2F4 antibody, E2F transcription factor 4 antibody, E2F-4 antibody, p107 binding transcription factor antibody, RB pathway transcription factor antibody, clone E2F4/4224 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.